Sort
50,496 grants matching “lung cancer”
Recognizing the tumor ecosystem: Integrating stromal and cancer antigen signals to achieve precision recognition of solid tumors by CAR T cells
$551,974Wendell A Lim · University Of California, San Francisco · R01 · FY2023 · CA
Genetic Loss-of-Function Studies of SETD2 in Kidney Tumorigenesis
$551,891Emily H Cheng · Sloan-Kettering Inst Can Research · R01 · FY2018 · CA
Exosomes as carriers of cancer therapeutics
$551,888Rajagopal Ramesh · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2022 · CA
Inherited genetic risk factors common to COPD and lung cancer.
$551,872James C Willey · University Of Toledo Health Sci Campus · R01 · FY2011 · HL
TAS::75 0872::TAS LUNG TISSUE RESEARCH CONSORTIUM CLINICAL CENTER
$551,854Andrew H Limper · Mayo Clinic Rochester · N01 · FY2011 · HL
Genetic Determinants of Tumor Growth and Drug Sensitivity in EGFR Mutant Lung Cancer
$551,847Katerina Abigail Politi · Yale University · R01 · FY2025 · CA
Preclinical Evaluation of Medications to Treat Polydrug Addiction
$551,836Nancy K. Mello · Mclean Hospital · R01 · FY2010 · DA
Elucidating pro-metastatic collagen modifying activities of lysyl hydroxylase 2
$551,809Jonathan M Kurie · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Population-Based Assessment of Cancer Trial Generalizability in the Elderly
$551,802Elizabeth B Lamont · Harvard Medical School · R01 · FY2008 · CA
Research Project 1: PDX-based trials of precision medicine for treatment of KRAS mutant lung cancers
$551,800Bingliang Fang · University Of Tx Md Anderson Can Ctr · U54 · FY2017 · CA
Functional Networks for Persister Cell Sensitivities
$551,800Michael T McManus · University Of California, San Francisco · R01 · FY2018 · CA
Exosomes as carriers of cancer therapeutics
$551,771Rajagopal Ramesh · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2024 · CA
Congenic Mouse Medels of Melanoma for the Characterization of Tumor Immune Responses
$551,750Marcus W Bosenberg · Yale University · R01 · FY2018 · CA
Congenic Mouse Medels of Melanoma for the Characterization of Tumor Immune Responses
$551,750Marcus W Bosenberg · Yale University · R01 · FY2017 · CA
Fabrication and Testing of a Novel PET insert for Simultaneous PET/MRI
$551,708Stuart S Berr · University Of Virginia · R01 · FY2021 · EB
CANCAN-RUTGERS
$551,676Eileen White · Rutgers Biomedical And Health Sciences · OT2 · FY2023 · CA
University of Washington/Fred Hutch Center for AIDS Research
$551,651Connie L Celum · University Of Washington · P30 · FY2023 · AI
Discovery of the next-generation RET-targeted drugs based on nicotinamide scaffold
$551,629Jie Wu · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2024 · CA
Biomarkers of NNK in prediction of lung cancer development in smokers
$551,628Jian-Min Yuan · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · CA
THE ROLE OF SOX2 IN LUNG CANCER INITIATION AND PROGRESSION
$551,561Duke University · · FY2010 · Department of the Army
Development of antibacterial agents and materials
$551,535Joel Schneider · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Serum Antibody Profiling with a Carbohydrate Microarray
$551,526Jeff Gildersleeve · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Project 3: Long Non-Coding RNAs and Cancer
$551,517David L Spector · Cold Spring Harbor Laboratory · P01 · FY2022 · CA
Air Pollution Particle Effects on Human Antimycobacterial Immunity
$551,481Stephan K Schwander · Rbhs-School Of Public Health · R01 · FY2013 · ES
Regulation of Ras-Dependent Signal Transduction Pathways
$551,428Deborah Morrison · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA